Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
2.870
-0.130 (-4.33%)
Mar 3, 2026, 4:00 PM EST - Market closed
Organogenesis Holdings Employees
Organogenesis Holdings had 854 employees as of December 31, 2025. The number of employees decreased by 15 or -1.73% compared to the previous year.
Employees
854
Change (1Y)
-15
Growth (1Y)
-1.73%
Revenue / Employee
$660,619
Profits / Employee
$23,445
Market Cap
369.20M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 854 | -15 | -1.73% |
| Dec 31, 2024 | 869 | 7 | 0.81% |
| Dec 31, 2023 | 862 | -168 | -16.31% |
| Dec 31, 2022 | 1,030 | 80 | 8.42% |
| Dec 31, 2021 | 950 | 40 | 4.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2001 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2000 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Canopy Growth | 960 |
| Emergent BioSolutions | 900 |
| Kamada | 420 |
| Lifecore Biomedical | 406 |
| Evolus | 329 |
| Ironwood Pharmaceuticals | 253 |
| Akebia Therapeutics | 181 |
| Aquestive Therapeutics | 142 |
ORGO News
- 5 days ago - Organogenesis Holdings Inc. (ORGO) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Organogenesis Holdings Inc. Reports Fourth Quarter 2025 Financial Results, Posts Record Revenue - GlobeNewsWire
- 12 days ago - Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026 - GlobeNewsWire
- 2 months ago - Organogenesis Announces Initiation of Biologics License Application for ReNu® - GlobeNewsWire
- 2 months ago - Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain - GlobeNewsWire
- 2 months ago - Organogenesis: High-Tech Skin Substitute Company On Sale - Seeking Alpha
- 4 months ago - Organogenesis Holdings Inc. (ORGO) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Organogenesis Holdings Inc. Reports Third Quarter 2025 Financial Results, Posts Record Revenue and Raises 2025 Guidance - GlobeNewsWire